News /

Filtered:

Research (Remove filters)

BioPorto receives Frost & Sullivan Award

Frost & Sullivan awards AKI Product Leadership Award to BioPorto

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Major organ surgery, Transplantation
Date

Product launch - Human NGAL monomer-specific ELISA

BioPorto launches the first human NGAL monomer specific assay. 

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity, AKI treatment, Other
Date

Product launch - recombinant NGAL antigens

An expansion of BioPorto Diagnostics extensive NGAL portfolio with 6 new Recombinant NGAL Antigens 

Read more
Category
Research
Clinical Relevance
Other
Date

Launch of NGAL Monkey antibodies

Diagnostics is pleased to announce the launch of our first-in class NGAL Monkey antibody portfolio

The launch of NGAL Monkey antibodies is yet another step in our continued efforts to raise the focus on nephrotoxicity in drug discovery, and it makes our range on kidney related antibodies the most comprehensive on the market.

Read more
Category
Research
Clinical Relevance
Nephrotoxicity
Date

Acute Kidney Biomarkers in focus in renown clinical issue

American Association for Clinical Chemistry (AACC) push for AKI biomarkers including NGAL in new cover story

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Major organ surgery, Transplantation
Date

AACC-CLINICAL LAB EXPO 2013

The Clinical Laboratory Expo is the world's largest gathering of clinical laboratory professionals and the largest exposition of clinical laboratory products and services of the year. 19,000 participants from more than 100 different countries are expected to attend the Clinical Lab Expo, including product development engineers, R&D executives, scientists, experts who develop the products and design used in the clinical diagnostics field.

Read more
Date
, 2013
Location
Houston, TX USA

The NGAL Test™ for users of Siemens VISTA and BC UniCel® DxC 800

We are happy to announce that The NGAL Test™ application notes are now available for the Siemens Dimension Vista® Integrated Chemistry System's nephelometric chanel and the turbidemetric analyzer from Beckman Coulter UniCel® DxC 800 Synchron® Clinical System. Both application notes are designed for urine samples only.

Read more
Category
Diagnostics, Research
Date

Product launch: Monkey NGAL ELISA Kit (KIT 045)

The Monkey NGAL ELISA Kit allows for the determination of rises in monkey NGAL concentrations. It is to be hoped that the determination of NGAL may become a convenient end-point in Rhesus and Cynomolgus monkey models of renal injury, nephrotoxicity and other nephropathies. With the launch of the Monkey NGAL ELISA Kit, the BioPorto research portfolio offers NGAL measurements for all animals most commonly used in drug development, safety and efficacy profiling.

Read more
Category
Research
Date

Focus meeting and NGAL workshop in the UK

The Focus meeting 2013 in York is one of the most important clinical science events in the United Kingdom (UK). Arranged by the association of clinical chemistry in the UK, the meeting attracts participants from all major UK healthcare laboratories and many university departments.

Read more
Category
Diagnostics, Research, Congress news
Date

World Kidney Day

BioPorto celebrates World Kidney Day and hopes that this year's focus on Acute Kidney Injury (AKI) will help raise awareness and further education on the importance of early diagnosis.

Ever since NGAL as a diagnostic biomarker was linked to AKI, NGAL has been given a central role in many international AKI initiatives. For more information on international initiatives please visit our links and resources page here

To learn more about World Kidney Day please visit: http://www.worldkidneyday.org/

Read more
Date
, 2013
Location

Better kidney markers ahead?

This is the question asked in a journalistic article recently published by College of American Pathologists.
The journalist has interviewed a handful of the worlds leading kidney researchers about their outlook on a future where earlier diagnosis and management of acute kidney injury is possible. The article gives an excellent review and status update on NGAL.

Please read the article here -

Better biomarkers ahead?

Read more
Category
Diagnostics, Research
Date

A new rapid NGAL assay for clinical chemistry platforms

A new assay simply known as The NGAL Test makes it possible to get an earlydiagnosis of acute kidney injury.

Read more
Category
Research
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity
Date

Product launch: Pig NGAL ELISA Kit (KIT 044)

Pig NGAL shows promise as an acute kidney injury marker using BioPorto Diagnostics new Pig NGAL ELISA Kit (KIT 044)

Read more
Category
Research
Date

New Dog NGAL ELISA

BioPorto Diagnostics has launched a new ELISA test for the determination of the acute kidney injury marker NGAL in urine, plasma and serum from dogs.

Read more
Category
Research
Clinical Relevance
Major organ surgery, Transplantation, Nephrotoxicity
Date

New Mouse NGAL ELISA

BioPorto Diagnostics has launched an ELISA test for the determination of the acute kidney injury marker NGAL in mice.

Read more
Category
Research
Date

New Rat NGAL ELISA

BioPorto Diagnostics has launched a new ELISA test for the determination of the acute kidney injury marker NGAL in rats.

Read more
Category
Research
Clinical Relevance
Nephrotoxicity
Date